1 unchanged sentence
Description of Exhibit
−Removed: Third Amended and Restated Certificate of Incorporation of Ingevity Corporation.
+Added: Transition Agreement dated as of June 26, 2024 between Ingevity Corporation and Stacy L.
+Added: Confidential Termination Agreement and Release, dated as of July 1, 2024, by and between GP Pine Chemicals, LLC and Ingevity Corporation (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, as filed with the U.S.
+Added: Securities and Exchange Commission on July 8, 2024).
+Added: Offer Letter between Ingevity Corporation and Terry Dyer dated July 3, 2024
+Added: Severance and Change of Control Agreement between Ingevity Corporation and Terry Dyer dated July 3, 2024
+Added: Offer Letter between Ingevity Corporation and Ryan C.
+Added: Fisher dated July 3, 2024
+Added: Severance and Change of Control Agreement between Ingevity Corporation and Ryan C.
+Added: Fisher dated July 3, 2024
Rule 13a-14(a)/15d-14(a) Certification of the Company’s Principal Executive Officer.
6 unchanged sentences
104 The cover page from the Company’s Quarterly Report on Form 10-Q formatted in Inline XBRL (included in Exhibit 101).
+Added: * Incorporated by reference.
+Added: + Management contract or compensatory plan or arrangement.
+Added: † Indicates that certain information has been omitted pursuant to Item 601(a)(5) of Regulation S-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
4 unchanged sentences
(Principal Financial Officer and Duly Authorized Officer)
+Added: August 1, 2024
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.